Endocyte Announces Presentation of Phase 2 Data from Investigator-Initiated Prostate Cancer Trial of 177Lu-PSMA-617 at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

World News: . []

WEST LAFAYETTE Ind May 16 2018 GLOBE NEWSWIRE -- Endocyte, Inc NasdaqECYT a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment today announced that a poster with data from the Peter MacCallum C ancer C...

More news and information about Endocyte, Inc.

Published By:

Globe Newswire: 23:05 GMT Wednesday 16th May 2018

Published: .

Search for other references to "endocyte" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us